Somewhat Favorable Press Coverage Somewhat Unlikely to Impact RTI Surgical (RTIX) Stock Price

News coverage about RTI Surgical (NASDAQ:RTIX) has been trending somewhat positive on Monday, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. RTI Surgical earned a daily sentiment score of 0.13 on Accern’s scale. Accern also assigned news stories about the medical equipment provider an impact score of 46.1843196454722 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Here are some of the news stories that may have impacted Accern Sentiment’s analysis:

Several equities research analysts have issued reports on RTIX shares. Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, October 13th. BidaskClub cut shares of RTI Surgical from a “hold” rating to a “sell” rating in a research report on Tuesday, December 5th.

RTI Surgical (NASDAQ:RTIX) traded up $0.15 during trading on Monday, reaching $4.45. 415,000 shares of the company’s stock traded hands, compared to its average volume of 191,500. The stock has a market cap of $270.70, a PE ratio of -63.57, a price-to-earnings-growth ratio of 1.98 and a beta of 1.76. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.21 and a current ratio of 3.34. RTI Surgical has a 12 month low of $3.01 and a 12 month high of $6.00.

RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.01. The company had revenue of $66.69 million during the quarter, compared to analysts’ expectations of $65.63 million. RTI Surgical had a net margin of 1.01% and a return on equity of 2.29%. RTI Surgical’s revenue for the quarter was up .2% on a year-over-year basis. research analysts predict that RTI Surgical will post 0.05 earnings per share for the current year.

WARNING: This article was originally reported by Equities Focus and is the property of of Equities Focus. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.equitiesfocus.com/2018/01/08/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-rti-surgical-rtix-stock-price.html.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Insider Buying and Selling by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply